University Hospital Munich, Department of Urology, Munich, Germany.
University Hospital Munich, Department of Urology, Munich, Germany.
Clin Genitourin Cancer. 2022 Aug;20(4):e283-e290. doi: 10.1016/j.clgc.2022.03.003. Epub 2022 Mar 7.
Radical cystectomy (RC) and urinary diversion by ileal conduit (IC) or ileal orthotopic neobladder (ONB) is the standard-of-care for surgical treatment of muscle-invasive bladder cancer. Yet, it is unclear how urinary diversion affects the patient's health-related quality of life (HRQOL) in the longer-term.
HRQOL was assessed preoperatively, 3mo postoperatively and then annually until a maximum follow-up of 48 months using the validated EORTC QLQ-C30- as well as the bladder cancer-specific FACT-BL- and QLQ-BLM30-questionnaires. A propensity-score matching for the variables "age," "ASA-classification," "cardiovascular co-morbidity," "sex" as well as "tumor stage," and "preoperative physical functioning score" was performed. Hypothetical predictors for decreased general HRQOL were analyzed using multivariable logistic regression models.
After propensity-score matching, 246 patients were analyzed. HRQOL assessment revealed significant differences regarding preoperative QLQ-C30 symptoms which diminished during the postoperative time course. Similarly, we did not find significant differences based on bladder cancer-specific FACT-BL and QLQ-BLM HRQOL assessment including body image (48 months: 29.6.4 [IC] vs. 40.7 [ONB]; P = .733). Regarding general HRQOL, we found increased global health status scores for ONB throughout the whole observational period without reaching statistical significance (48 months: 55.0 [IC] vs. 70.1 [ONB]; P = .079). In multivariate analysis, cardiovascular comorbidity was an independent predictor of impaired HRQOL 24 months (HR 2.20; CI95% 1.02-5.72, P = .044) and 36 months (HR 6.84; CI95% 1.61-29.14, P = .009) postoperatively.
We did not observe significant differences in bladder-specific as well as generic HRQOL in the longer-term and consequently, the type of urinary diversion was not an independent predictor of good general HRQOL in a follow-up period of 4 years.
根治性膀胱切除术(RC)和回肠导管(IC)或回肠原位新膀胱(ONB)的尿流改道术是肌层浸润性膀胱癌的标准治疗方法。然而,目前尚不清楚尿流改道在较长时间内如何影响患者的健康相关生活质量(HRQOL)。
使用经过验证的 EORTC QLQ-C30 以及膀胱癌特异性 FACT-BL 和 QLQ-BLM30 问卷,在术前、术后 3 个月以及最多 48 个月的时间内,每年评估 HRQOL。针对“年龄”、“ASA 分级”、“心血管合并症”、“性别”以及“肿瘤分期”和“术前身体功能评分”等变量进行倾向评分匹配。使用多变量逻辑回归模型分析一般 HRQOL 下降的假设预测因子。
经过倾向评分匹配,对 246 名患者进行了分析。HRQOL 评估显示,术前 QLQ-C30 症状存在显著差异,这些症状在术后期间有所减轻。同样,我们在基于膀胱癌特异性 FACT-BL 和 QLQ-BLM HRQOL 评估方面没有发现显著差异,包括身体形象(48 个月:IC 为 29.6.4,ONB 为 40.7;P=0.733)。关于一般 HRQOL,我们发现 ONB 的整体健康状况评分在整个观察期内增加,但没有达到统计学意义(48 个月:IC 为 55.0,ONB 为 70.1;P=0.079)。在多变量分析中,心血管合并症是术后 24 个月(HR 2.20;95%CI 1.02-5.72,P=0.044)和 36 个月(HR 6.84;95%CI 1.61-29.14,P=0.009)时 HRQOL 受损的独立预测因子。
我们在较长时间内没有观察到膀胱癌特异性和一般 HRQOL 方面的显著差异,因此,在 4 年的随访期内,尿流改道的类型不是一般 HRQOL 的独立预测因子。